Correlation Between Tempest Therapeutics and Celularity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Celularity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Celularity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Celularity, you can compare the effects of market volatilities on Tempest Therapeutics and Celularity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Celularity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Celularity.

Diversification Opportunities for Tempest Therapeutics and Celularity

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tempest and Celularity is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Celularity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celularity and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Celularity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celularity has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Celularity go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Celularity

Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Celularity. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 4.47 times less risky than Celularity. The stock trades about -0.12 of its potential returns per unit of risk. The Celularity is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.88  in Celularity on August 29, 2024 and sell it today you would lose (0.31) from holding Celularity or give up 16.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy86.96%
ValuesDaily Returns

Tempest Therapeutics  vs.  Celularity

 Performance 
       Timeline  
Tempest Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Celularity 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Celularity are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Celularity showed solid returns over the last few months and may actually be approaching a breakup point.

Tempest Therapeutics and Celularity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tempest Therapeutics and Celularity

The main advantage of trading using opposite Tempest Therapeutics and Celularity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Celularity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will offset losses from the drop in Celularity's long position.
The idea behind Tempest Therapeutics and Celularity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios